Mirion Technologies concurrent stock and convertible notes offerings
We advised Mirion Technologies on its $425 million stock offering and concurrent $375 million convertible notes offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
MBX Biosciences $200 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Laekna HK$587 million placement of shares
We advised Laekna on the placement of new shares
Oruka Therapeutics $180 million private placement
The PIPE included common stock and pre-funded warrants
Norwegian Cruise Line Holdings comprehensive refinancing transactions
The transactions included new debt, exchangeable debt, registered direct equity offerings and concurrent tender offers
Strive Nasdaq listing and $450 million at-the-market offering
We advised Strive on its Nasdaq listing and offering
Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
Customers Bancorp $172.5 million stock offering
The shares are listed on the New York Stock Exchange
dLocal $220 million secondary offering
We advised dLocal on the offering
Hamilton Lane $77.5 million follow-on offering
The shares are listed on Nasdaq